Covaxin, developed by the Indian Council of Medical Research (ICMR) and Bharat Biotech, is being tested at 12 institutes across India.
Indian covid Vaccine is safe.
Coronavirus vaccine Covaxin is successful on trial on monkey.
Bharat biotech has asked CDSCO for trial and same is approved for phase 2 trial.
ICMR, National institute of Virology, NIV jointly with Bharat Biotech developed Covaxin.
Bharat Biotech proudly announces the animal study results of COVAXIN™ – These results demonstrate the protective efficacy in a live viral challenge model.
A 2-dose vaccination regimen of inactivated SARS-CoV-2 vaccine candidates was administered in 20 rhesus macaques (divided into four groups equally).
One group was administered with placebo, while three groups were immunized with 3 different vaccine candidates at 0 and 14 days. All the macaques were exposed to viral challenge 14 days after the 2nd dose.
Adverse events were not seen in animals immunized with a two-dose vaccination regimen.
The vaccine candidate was found to generate robust immune responses. Thus, preventing infection and disease in the primates upon high amounts of exposure to live SARS-CoV-2 virus.